Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES

Approved

STANDARD

OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES

Takeda France S.A.S.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 17, 2024
Approval ID: 609b906df65b8abb
Company: Takeda France S.A.S.
Type: Standard

Approval Details

Approval Id: 609b906df65b8abb
Drug Cima Aemps Name: OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES
Register Number: 3400936871441
Holder Company Name: Takeda France S.A.S.
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2024-05-17
Dosage Form: COMPRIMIDO BUCODISPERSABLE
Dose: 30 mg lansoprazol
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Takeda France S.A.S.

Active Ingredients

LANSOPRAZOL

30,0 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 17, 2024

Approval ID

609b906df65b8abb

Type

Standard

Back to CIMA-AEMPS Approvals